ONCO/Reveal Myeloid Panel

The ONCO/Reveal Myeloid Panel is a robust NGS assay that interrogates 58 genes of interest* most relevant to myeloid cancer. The panel uses proprietary Stem-Loop Inhibition-Mediated amplification (SLIMamp®) technology for efficient single-tube target enrichment.

Benefits:

  • Requires as little as 10 ng of input DNA
  • Detection of 1% allele frequency in somatic cancers
  • Single sample / single well assay technology for enhanced sensitivity
  • Automatable sample processing
Myeloid Panel Target Genes (58 in total)
ABL1 BRAF CEBPA ETV6 HRAS KDM6A NPM1 PTEN SMC1A TP53
ANKRD26 CALR CSF3R EZH2 IDH1 KIT NRAS PTPN11 SMC3 U2AF1
ASXL1 CBL CUX1 FLT3 IDH2 KMT2A PDGFRA RAD21 SRSF2 WT1
ATRX CBLB DDX41 GATA1 IKZF1 KRAS PHF6 RUNX1 STAG1 ZRSR2
BCOR CBLC DNMT3A GATA2 JAK2 MPL PIGA SETBP1 STAG2
BCORL1 CDKN2A ETNK1 GNAS JAK3 NF1 PPM1D SF3B1 TET2
 

*Panel content was designed in accordance with the Association for Molecular Pathology (AMP) guidelines and incorporates guidance from multiple hematologists.